12/3
12:19 pm
femy
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
12/3
09:07 am
femy
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed [Yahoo! Finance]
Medium
Report
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed [Yahoo! Finance]
12/3
09:00 am
femy
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed
Medium
Report
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed
11/27
08:05 am
femy
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/26
08:38 am
femy
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment [Yahoo! Finance]
Medium
Report
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment [Yahoo! Finance]
11/26
08:30 am
femy
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment
Medium
Report
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment
11/13
06:51 pm
femy
Femasys Inc. (NASDAQ: FEMY) had its price target lowered by analysts at Chardan Capital from $10.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Femasys Inc. (NASDAQ: FEMY) had its price target lowered by analysts at Chardan Capital from $10.00 to $8.00. They now have a "buy" rating on the stock.
11/12
12:35 pm
femy
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/12
11:02 am
femy
Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
11/12
10:43 am
femy
Femasys GAAP EPS of -$0.24, revenue of $554.91M [Seeking Alpha]
Medium
Report
Femasys GAAP EPS of -$0.24, revenue of $554.91M [Seeking Alpha]
11/12
08:30 am
femy
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
Medium
Report
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
11/7
08:38 am
femy
Zealand Pharma A/S (ZLDPF) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
Low
Report
Zealand Pharma A/S (ZLDPF) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
11/7
08:30 am
femy
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
Low
Report
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
11/1
08:30 am
femy
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
Medium
Report
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
10/31
08:35 am
femy
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
10/30
09:00 am
femy
Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed
Neutral
Report
Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed
10/10
08:30 am
femy
Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program
Low
Report
Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program
10/8
08:30 am
femy
Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Medium
Report
Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
10/2
08:30 am
femy
Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments
Neutral
Report
Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments